These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33821528)

  • 21. Piecewise mixed-effects models with skew distributions for evaluating viral load changes: A Bayesian approach.
    Huang Y; Dagne GA; Zhou S; Wang Z
    Stat Methods Med Res; 2015 Dec; 24(6):730-46. PubMed ID: 22045781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Likelihood ratio tests for a dose-response effect using multiple nonlinear regression models.
    Gutjahr G; Bornkamp B
    Biometrics; 2017 Mar; 73(1):197-205. PubMed ID: 27399200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nonlinear mixed-effect mixture model for functional mapping of dynamic traits.
    Hou W; Li H; Zhang B; Huang M; Wu R
    Heredity (Edinb); 2008 Oct; 101(4):321-8. PubMed ID: 18612322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative investigation of methods for longitudinal data with limits of detection through a case study.
    Fu P; Hughes J; Zeng G; Hanook S; Orem J; Mwanda OW; Remick SC
    Stat Methods Med Res; 2016 Feb; 25(1):153-66. PubMed ID: 22504231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing antiviral potency of anti-HIV therapies in vivo by comparing viral decay rates in viral dynamic models.
    Ding AA; Wu H
    Biostatistics; 2001 Mar; 2(1):13-29. PubMed ID: 12933554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generalized linear mixed model for binary outcomes when covariates are subject to measurement errors and detection limits.
    Xie X; Xue X; Strickler HD
    Stat Med; 2018 Jan; 37(1):119-136. PubMed ID: 28980332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Constrained inference in mixed-effects models for longitudinal data with application to hearing loss.
    Davidov O; Rosen S
    Biostatistics; 2011 Apr; 12(2):327-40. PubMed ID: 20719782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A generalized Bayesian nonlinear mixed-effects regression model for zero-inflated longitudinal count data in tuberculosis trials.
    Burger DA; Schall R; Jacobs R; Chen DG
    Pharm Stat; 2019 Jul; 18(4):420-432. PubMed ID: 30957394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bayesian semiparametric modeling for HIV longitudinal data with censoring and skewness.
    Castro LM; Wang WL; Lachos VH; Inácio de Carvalho V; Bayes CL
    Stat Methods Med Res; 2019 May; 28(5):1457-1476. PubMed ID: 29551086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence assessment in censored mixed-effects models using the multivariate Student's-
    Matos LA; Bandyopadhyay D; Castro LM; Lachos VH
    J Multivar Anal; 2015 Oct; 141():104-117. PubMed ID: 26190871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Censored linear regression models for irregularly observed longitudinal data using the multivariate- t distribution.
    Garay AM; Castro LM; Leskow J; Lachos VH
    Stat Methods Med Res; 2017 Apr; 26(2):542-566. PubMed ID: 25296865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling HIV-RNA viral load in vertically infected children.
    Gray L; Cortina-Borja M; Newell ML
    Stat Med; 2004 Mar; 23(5):769-81. PubMed ID: 14981674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maximum likelihood inference for left-censored HIV RNA data.
    Lynn HS
    Stat Med; 2001 Jan; 20(1):33-45. PubMed ID: 11135346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some alternatives to asymptotic tests for the analysis of pharmacogenetic data using nonlinear mixed effects models.
    Bertrand J; Comets E; Chenel M; Mentré F
    Biometrics; 2012 Mar; 68(1):146-55. PubMed ID: 22049987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation by simulation of tests based on non-linear mixed-effects models in pharmacokinetic interaction and bioequivalence cross-over trials.
    Panhard X; Mentré F
    Stat Med; 2005 May; 24(10):1509-24. PubMed ID: 15761916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A bayesian approach to joint mixed-effects models with a skew-normal distribution and measurement errors in covariates.
    Huang Y; Dagne G
    Biometrics; 2011 Mar; 67(1):260-9. PubMed ID: 20486924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonlinear mixed-effects models with misspecified random-effects distribution.
    Drikvandi R
    Pharm Stat; 2020 May; 19(3):187-201. PubMed ID: 31663263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The SAEM algorithm for group comparison tests in longitudinal data analysis based on non-linear mixed-effects model.
    Samson A; Lavielle M; Mentré F
    Stat Med; 2007 Nov; 26(27):4860-75. PubMed ID: 17562540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous inference for longitudinal data with detection limits and covariates measured with errors, with application to AIDS studies.
    Wu L
    Stat Med; 2004 Jun; 23(11):1715-31. PubMed ID: 15160404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
    Bazzoli C; Retout S; Mentré F
    Stat Med; 2009 Jun; 28(14):1940-56. PubMed ID: 19266541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.